menu

ReachMD

Be part of the knowledge.
Register

ReachMD is even better when
you join the community!
Registration is free and easy.

Register Now

Rheumatoid Arthritis: Challenges and Opportunities in the Evolving Treatment Landscape

In this interview, Dr. Gibofsky will be assessing disease activity and targeted treatment by applying the 2015 ACR guidelines for treating patients...

Available credits: 0.50

Time to complete: 30 minutes

Released:

Valid until:

Take Post-Test

If you’ve already completed the activity.

  • Overview

    In this interview, Dr. Gibofsky will be assessing disease activity and targeted treatment by applying the 2015 ACR guidelines for treating patients with rheumatoid arthritis. 

  • Target Audience

    This activity has been designed to address the educational needs of rheumatologists. This activity will also be of benefit to other healthcare practitioners interested in the management of rheumatoid arthritis.

  • Learning Objectives

    Upon proper completion of this activity, participants should be better able to:

    • Identify patients with rheumatoid arthritis who may benefit from approved and emerging biologic disease-modifying antirheumatic drugs (DMARDs), including undertreated patients and patients with early disease, based on mechanism of action, clinical efficacy and safety data, and their unique clinical profiles.
    • Describe available tools for monitoring rheumatoid arthritis disease activity and progression and their utility in optimizing therapy.
    • Recognize how patient history and disease duration influence patient response to biologic DMARDs for rheumatoid arthritis.
  • Accreditation and Credit Designation Statements

    This activity is provided by Global Education Group. Paradigm Medical Communications, LLC is the educational partner.

     

    Accreditation Statement

    Global Education Group is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

    This CME/CE activity complies with all requirements of the federal Physician Payment Sunshine Act. If a reportable event is associated with this activity, the accredited provider managing the program will provide the appropriate physician data to the Open Payments database.

    Credit Designation Statement

    Global Education Group designates this enduring material for a maximum of 0.5 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

    For information about the accreditation of this program, please contact Global at (303) 395-1782 or inquire@globaleducationgroup.com.

    Contact Us

    If you have any questions or comments, please email us at contactus@paradigmmc.com.

    © 2017 Paradigm Medical Communications, LLC, except where noted. Content may not be reproduced in whole or part without the express written permission of Paradigm Medical Communications, LLC.

  • Commercial Support

    This activity is supported by an educational grant from Lilly.

  • Disclosure of Conflicts of Interest

    Global Education Group (Global) and Paradigm Medical Communications, LLC, (Paradigm) require instructors, planners, managers, and other individuals and their spouse/life partner who are in a position to control the content of this activity to disclose any real or apparent conflict of interest they may have as related to the content of this activity. All identified conflicts of interest are thoroughly vetted by Global and Paradigm for fair balance, scientific objectivity of studies mentioned in the materials or used as the basis for content, and appropriateness of patient care recommendations.

    The faculty reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Faculty or Presenter

    Reported Financial Relationship

    Allan Gibofsky, MD, JD, MACR, FACP, FCLM

    Retained Consultant: Eli Lilly and Company (self)

    Speakers Bureau: AbbVie Inc, Celgene Corporation, Novartis, Pfizer Inc, UCB, Inc. (self)

    Stockholder: AbbVie Inc, Amgen Inc, Bristol-Myers Squibb Company,  GlaxoSmithKline, Johnson and Johnson Services, Inc, Pfizer Inc, Regeneron Pharmaceuticals, Inc. (self and spouse/partner)

    Name of Host

    Reported Financial Relationship

    Jennifer Caudle, DO

    No financial relationships to disclose

    The planners and managers reported the following financial relationships or relationships to products or devices they or their spouse/life partner have with commercial interests related to the content of this CME activity:

    Name of Planner or Manager

    Reported Financial Relationship

    Laura Gilsdorf

    No financial relationships to disclose

    Paradigm Medical Communications, LLC staff members have no financial relationships to disclose.

    Independent peer reviewer has no financial relationships to disclose.

  • Disclaimer

    Participants have an implied responsibility to use the newly acquired information to enhance patient outcomes and their own professional development. The information presented in this activity is not meant to serve as a guideline for patient management. Any procedures, medications, or other courses of diagnosis or treatment discussed in this activity should not be used by clinicians without evaluation of patient conditions and possible contraindications on dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities.

    Disclosure of Unlabeled Use
    This educational activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Global and Paradigm do not recommend the use of any agent outside of the labeled indications.

    The opinions expressed in the educational activity are those of the faculty and do not necessarily represent the views of any organization associated with this activity. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings.

  • Terms of Use

    Disclaimer
    The materials provided for this activity are for informational purposes only, and should not be used for diagnosis or treatment of a health problem without consulting a licensed medical professional. Any views or opinions presented are solely those of the Faculty, and do not necessarily represent those of Global Education Group or Paradigm Medical Communications, LLC. References to any entity, product, service, or source of information on this website should not be considered an endorsement, either direct or implied, by Global or Paradigm. Global and Paradigm accept no liability for the content referenced in this activity.

  • Instructions

    To receive a CME certificate of participation, participants must:

    • Follow instructions to register or log in with your professional information and complete the pretest.
    • View the online activity in its entirety. 
    • Complete and submit the online posttest and evaluation. You must answer 70% of the posttest questions correctly to earn credit. You will have unlimited opportunities to successfully complete the posttest.

    A certificate of participation will be available for download/printing immediately following your successful completion of the posttest and evaluation.

    For questions regarding CME credit, contact the Paradigm CME Department at (845) 398-5949.

    There is no fee required for participation in this activity.

  • System Requirements

    Our site requires a computer, tablet or mobile device and a connection to the Internet. For best results, a high-speed Internet connection is recommended (DSL/cable). We also recommend using the latest version of your favorite browser to ensure compliance with W3C standards, such as Internet Explorer, Microsoft Edge, Chrome, Firefox or Safari. Users accustomed to IE8, IE9 IE10 are advised to update their browsers for the best experience."

Facebook Comments

LIVE ON REACHMD RADIOBack to live radio
ReachMD Radio

Loading...

00:00
00:00

    You must be in to display playlists.

    Get a Dose of ReachMD in Your Inbox
    and Practice Smarter Medicine

    Stay current with the best in medical education.